Lomitapide Mesylate

CHEMBL2105662 Phase 4 Aprobado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

789.8 g/mol

LogP

—

Phase

4

The mesylate salt form of lomitapide, used to treat homozygous familial hypercholesterolemia. It is the pharmaceutical form approved for reducing dangerously elevated LDL cholesterol levels.

Peso molecular

789,8000 g/mol

TPSA

124,00 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CS(=O)(=O)O.O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1

InChI

InChI=1S/C39H37F6N3O2.CH4O3S/c40-38(41,42)25-46-36(50)37(33-13-5-3-10-30(33)31-11-4-6-14-34(31)37)21-7-8-22-48-23-19-28(20-24-48)47-35(49)32-12-2-1-9-29(32)26-15-17-27(18-16-26)39(43,44)45;1-5(2,3)4/h1-6,9-18,28H,7-8,19-25H2,(H,46,50)(H,47,49);1H3,(H,2,3,4)

Molecular Formula

C40H41F6N3O5S

HBD / HBA

3 / 12

Enlaces Rotables

10

Átomos Pesados

55

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

The mesylate salt form of lomitapide, used to treat homozygous familial hypercholesterolemia. It is the pharmaceutical form approved for reducing dangerously elevated LDL cholesterol levels.

Yes, Lomitapide Mesylate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2105662. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 11274333. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

¿Busca información accesible para el paciente?

Lomitapide Mesylate en PillFYI

Estructura

Datos Rápidos

Fórmula: C40H41F6N3O5S
Sinónimos: 1

Enlaces externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.